Stem cells are cells which have the ability to differentiate into various types of other cells and ultimately form organs or tissues. Stem cells are mainly of two type embryonic stem cells and adult stem cells. Over the years many researchers have carried out studies to evaluate the true potential of stem cells leading to various applications in the field of organ regeneration, genetic diseases treatment, oncology and cell therapy in damaged cells.
Market Industry Reports (MIR) has published a new report titled "Stem Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report The global stem cell therapy market was valued at over US$ 103 Mn in 2018 and is anticipated to grow at a CAGR of 9.8% from 2019 to 2030. The major factors driving the growth of the market include increasing burden of chronic diseases, growing investment in R&D, and technological developments in biotech and pharmaceutical industry.
Major Key Players of the Stem Cell Therapy Market are:
Osiris, MEDIPOST, Anterogen, PHARMICELL Co., Holostem Terapie Avanzate S.r.l, .JCR Pharmaceuticals Co., NuVasive, Inc., RTI Surgical, Inc, and AlloSource
Read More @ http://www.sbwire.com/press-releases/stem-cell-therapy-market-emerging-technological-advancement-future-scope-and-business-growth-2030-osiris-medipost-anterogen-1282198.htm
Market Industry Reports (MIR) has published a new report titled "Stem Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report The global stem cell therapy market was valued at over US$ 103 Mn in 2018 and is anticipated to grow at a CAGR of 9.8% from 2019 to 2030. The major factors driving the growth of the market include increasing burden of chronic diseases, growing investment in R&D, and technological developments in biotech and pharmaceutical industry.
Major Key Players of the Stem Cell Therapy Market are:
Osiris, MEDIPOST, Anterogen, PHARMICELL Co., Holostem Terapie Avanzate S.r.l, .JCR Pharmaceuticals Co., NuVasive, Inc., RTI Surgical, Inc, and AlloSource
Read More @ http://www.sbwire.com/press-releases/stem-cell-therapy-market-emerging-technological-advancement-future-scope-and-business-growth-2030-osiris-medipost-anterogen-1282198.htm
No comments:
Post a Comment